Cardinal Health Inc. (CAH - Free Report) is a healthcare services company engaged in providing pharmaceutical and medical products and services in the United States and International markets. The company primarily operates in two segments, Pharmaceutical and Medical.

Currently, Cardinal Health has a Zacks Rank #4 (Sell) but that could change following its third-quarter fiscal 2017 earnings report which has just released. (You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. We have highlighted some of the key details from the just-released announcement below:

Earnings: Cardinal Health’s adjusted earnings rose 7% on a year-over-year basis to $1.53 per share. It also managed to outpace the Zacks Consensus Estimate of $1.46.
 
Revenues: Revenues increased 4% on a year-over-year basis to $31.8 billion. It however came below the Zacks Consensus Estimate of $32.5 billion.
 
Key Stats: Pharmaceutical revenues surged 3% to $28.4 billion while revenues from Medical segment increased 9% to $3.4 billion in the quarter.
 

Cardinal Health, Inc. Price and EPS Surprise

Cardinal Health, Inc. Price and EPS Surprise | Cardinal Health, Inc. Quote

Major Factors: Pharmaceutical segment revenues increased due to strong growth from the Specialty business and higher number of Pharmaceutical Distribution business customers. Higher contributions from net new and existing customers were primarily responsible for the growth in Medical segment revenues.